Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

Angela R. Branche, Nadine G. Rouphael, David J. Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden, Sharon E. Frey, Jennifer A. Whitaker, Susan J. Little, View ORCID ProfileEvan J. Anderson, Emmanuel B. Walter, Richard M. Novak, Richard Rupp, Lisa A. Jackson, Tara M. Babu, Angelica C. Kottkamp, Anne F. Luetkemeyer, Lilly C. Immergluck, Rachel M. Presti, Martín Bäcker, Patricia L. Winokur, Siham M. Mahgoub, Paul A. Goepfert, Dahlene N. Fusco, Elissa Malkin, Jeffrey M. Bethony, Edward E. Walsh, Daniel S. Graciaa, Hady Samaha, Amy C. Sherman, Stephen R. Walsh, Getahun Abate, Zacharoula Oikonomopoulou, Hana M. El Sahly, Thomas C.S. Martin, Christina A. Rostad, Michael J. Smith, Benjamin G. Ladner, Laura Porterfield, Maya Dunstan, Anna Wald, Tamia Davis, Robert L. Atmar, Mark J. Mulligan, Kirsten E. Lyke, Christine M. Posavad, Megan A. Meagher, David S. Stephens, Kathleen M. Neuzil, Kuleni Abebe, Heather Hill, Jim Albert, Teri C. Lewis, Lisa A. Giebeig, Amanda Eaton, Antonia Netzl, Samuel H. Wilks, Sina Türeli, Mamodikoe Makhene, Sonja Crandon, Marina Lee, Seema U. Nayak, David C. Montefiori, Mat Makowski, Derek J. Smith, Paul C. Roberts, John H. Beigel, the COVAIL Study Group
doi: https://doi.org/10.1101/2022.07.12.22277336
Angela R. Branche
1Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Angela_branche@urmc.rochester.edu
Nadine G. Rouphael
2Hope Clinic, Emory Vaccine Center, Decatur, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Diemert
3George Washington University, Washington, DC
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann R. Falsey
1Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Losada
2Hope Clinic, Emory Vaccine Center, Decatur, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsey R. Baden
4Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon E. Frey
5Saint Louis University, School of Medicine, Saint Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer A. Whitaker
6Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan J. Little
7Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan J. Anderson
8Center for Childhood Infections and Vaccines (CCIV) of Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evan J. Anderson
Emmanuel B. Walter
9Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard M. Novak
10University of Illinois at Chicago-Project WISH, Chicago, IL
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Rupp
11University of Texas Medical Branch, Galveston, TX
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa A. Jackson
12Kaiser Permanente Washington Health Research Institute, Seattle, WA
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara M. Babu
13Department of Medicine, University of Washington, Seattle, Washington, WA
MD, MSCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelica C. Kottkamp
14New York University VTEU, Manhattan Research Clinic at NYU Grossman School of Medicine, New York, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne F. Luetkemeyer
15Zuckerberg San Francisco General, University of California San Francisco, San Francisco, CA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lilly C. Immergluck
16Morehouse School of Medicine, Atlanta, GA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel M. Presti
17Washington University School of Medicine, Saint Louis, MO
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martín Bäcker
18New York University VTEU, Long Island Research Clinic at NYU Long Island School of Medicine, New York, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia L. Winokur
19University of Iowa College of Medicine, Iowa City, IA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siham M. Mahgoub
20Howard University College of Medicine, Howard University Hospital, Washington, DC
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. Goepfert
21University of Alabama at Birmingham, Birmingham, AL
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dahlene N. Fusco
22Tulane University School of Medicine, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elissa Malkin
3George Washington University, Washington, DC
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey M. Bethony
3George Washington University, Washington, DC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward E. Walsh
1Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel S. Graciaa
2Hope Clinic, Emory Vaccine Center, Decatur, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hady Samaha
2Hope Clinic, Emory Vaccine Center, Decatur, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy C. Sherman
4Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen R. Walsh
4Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Getahun Abate
5Saint Louis University, School of Medicine, Saint Louis, MO
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zacharoula Oikonomopoulou
5Saint Louis University, School of Medicine, Saint Louis, MO
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hana M. El Sahly
6Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas C.S. Martin
7Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina A. Rostad
8Center for Childhood Infections and Vaccines (CCIV) of Children’s Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Smith
9Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
MD, MSCE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin G. Ladner
10University of Illinois at Chicago-Project WISH, Chicago, IL
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Porterfield
11University of Texas Medical Branch, Galveston, TX
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maya Dunstan
12Kaiser Permanente Washington Health Research Institute, Seattle, WA
MS, RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Wald
23Departments of Medicine, Epidemiology, and Laboratory Medicine & Pathology, University of Washington, Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamia Davis
14New York University VTEU, Manhattan Research Clinic at NYU Grossman School of Medicine, New York, NY
NP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert L. Atmar
6Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Mulligan
14New York University VTEU, Manhattan Research Clinic at NYU Grossman School of Medicine, New York, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten E. Lyke
24Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine M. Posavad
23Departments of Medicine, Epidemiology, and Laboratory Medicine & Pathology, University of Washington, Vaccines and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA
25IDCRC Laboratory Operations Unit, Fred Hutchinson Cancer Center, Seattle, WA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan A. Meagher
25IDCRC Laboratory Operations Unit, Fred Hutchinson Cancer Center, Seattle, WA
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David S. Stephens
26Emory University, Atlanta, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen M. Neuzil
24Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuleni Abebe
27FHI360, Durham, NC
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Hill
28The Emmes Company, LLC, Rockville, MD
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jim Albert
28The Emmes Company, LLC, Rockville, MD
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teri C. Lewis
29Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa A. Giebeig
29Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Eaton
9Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
30The Department of Surgery, Duke University Medical Center, Durham, NC
MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonia Netzl
31Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel H. Wilks
31Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
PhD, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sina Türeli
31Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mamodikoe Makhene
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonja Crandon
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
BSN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina Lee
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seema U. Nayak
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Montefiori
9Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
30The Department of Surgery, Duke University Medical Center, Durham, NC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mat Makowski
28The Emmes Company, LLC, Rockville, MD
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek J. Smith
31Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul C. Roberts
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John H. Beigel
32National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Protection from SARS-CoV-2 vaccines wanes over time and is compounded by emerging variants including Omicron subvariants. This study evaluated safety and immunogenicity of SARS-CoV-2 variant vaccines.

Methods This phase 2 open-label, randomized trial enrolled healthy adults previously vaccinated with a SARS-CoV-2 primary series and a single boost. Eligible participants were randomized to one of six Moderna COVID19 mRNA vaccine arms (50µg dose): Prototype (mRNA-1273), Omicron BA.1+Beta (1 or 2 doses), Omicron BA.1+Delta, Omicron BA.1 monovalent, and Omicron BA.1+Prototype. Neutralization antibody titers (ID50) were assessed for D614G, Delta, Beta and Omicron BA.1 variants and Omicron BA.2.12.1 and BA.4/BA.5 subvariants 15 days after vaccination.

Results From March 30 to May 6, 2022, 597 participants were randomized and vaccinated. Median age was 53 years, and 20% had a prior SARS-CoV-2 infection. All vaccines were safe and well-tolerated. Day 15 geometric mean titers (GMT) against D614G were similar across arms and ages, and higher with prior infection. For uninfected participants, Day 15 Omicron BA.1 GMTs were similar across Omicron-containing vaccine arms (3724-4561) and higher than Prototype (1,997 [95%CI:1,482-2,692]). The Omicron BA.1 monovalent and Omicron BA.1+Prototype vaccines induced a geometric mean ratio (GMR) to Prototype for Omicron BA.1 of 2.03 (97.5%CI:1.37-3.00) and 1.56 (97.5%CI:1.06-2.31), respectively. A subset of samples from uninfected participants in four arms were also tested in a different laboratory at Day 15 for neutralizing antibody titers to D614G and Omicron subvariants BA.1, BA.2.12.2 and BA.4/BA.5. Omicron BA.4/BA.5 GMTs were approximately one third BA.1 GMTs (Prototype 517 [95%CI:324-826] vs. 1503 [95%CI:949-2381]; Omicron BA.1+Beta 628 [95%CI:367-1,074] vs. 2125 [95%CI:1139-3965]; Omicron BA.1+Delta 765 [95%CI:443-1,322] vs. 2242 [95%CI:1218-4128] and Omicron BA.1+Prototype 635 [95%CI:447-903] vs. 1972 [95%CI:1337-2907).

Conclusions Higher Omicron BA.1 titers were observed with Omicron-containing vaccines compared to Prototype vaccine and titers against Omicron BA.4/BA.5 were lower than against BA.1 for all candidate vaccines.

Clinicaltrials.gov NCT05289037

Competing Interest Statement

ARB has research grants from Pfizer, Janssen, Merck Sharp and Dohme and CyanVac and serves on the DSMB board for AzurX Biopharma and has served as a consultant for Janssen. ARF has research grants from Pfizer, Janssen, CyanVac, Merck Sharp and Dohme and BioFire Diagnostics and serves on the DSMB for Novavax. EW has research grants from Janssen, Merck Sharp and Dohme and Pfizer and served on a DSMB sponsored by GlaxoSmithKline. NGR has research grants from Pfizer, Sanofi Pasteur, Merck Sharp and serves on the Safety Monitoring Committees for ICON and EMMES. DSG receives consulting fees from Critica, Inc a non-profit organization. LRB has received grant support from NIH for SARS-CoV-2 therapeutic and vaccine development work and is involved in SARS-CoV-2 vaccine trials conducted in collaboration with the NIH, Covid Prevention Network (CoVPN), Crucell/Janssen, Moderna, and Harvard Medical School. SRW has conducted clinical trials funded by Sanofi Pasteur, Janssen Vaccines, ModernaTx, and NIAID/NIH and chairs an Independent Data Monitoring Committee (IDMC) for Janssen Vaccines. CMH is a member of a Safety Monitoring Committee for the Emmes Corporation. SJL has received research grant support to UCSD from Gilead Sciences. Her institution has also received funding from NIH to conduct clinical trials of Janssen and AstraZeneca COVID-19 vaccines. EJA has consulted for Pfizer, Sanofi Pasteur, Janssen, GSK, Moderna, and Medscape, and his institution receives funds to conduct clinical research unrelated to this manuscript from MedImmune, Regeneron, PaxVax, Pfizer, GSK, Merck, Sanofi-Pasteur, Janssen, and Micron. He also serves on data and safety monitoring boards for Kentucky BioProcessing, Inc. and Sanofi Pasteur. He also serves on safety monitoring committees for WCG-ACI Clinical. His institution has also received funding from NIH to conduct clinical trials of Moderna and Janssen COVID-19 vaccines. The institution for SK has received funding from CDC to conduct clinical research unrelated to this manuscript, from NIH to conduct clinical trials of Moderna and Janssen COVID-19 vaccines, and from Pfizer to conduct clinical trials of Pfizer COVID-19 vaccine. The institution for CAR has received funds to conduct clinical research unrelated to this manuscript from BioFire Inc, GSK, MedImmune, Micron, Janssen, Merck, Novavax, PaxVax, Regeneron, Sanofi-Pasteur. She is co-inventor of patented RSV vaccine technology unrelated to this manuscript, which has been licensed to Meissa Vaccines, Inc. Her institution has received funds from NIH, Moderna, Pfizer, and Janssen to conduct clinical trials of COVID-19 vaccines. EBW has served as an investigator for vaccine studies sponsored by Pfizer, Moderna and Sequiris. He has served on advisory boards for Vaxcyte and Iliad Biotechnologies. MJS has served as an investigator for vaccine studies sponsored by Pfizer, and has received investigator-initiated grants from Merck related to antimicrobial stewardship. RMN has received research grant funding from ModernaTX, Inc and Janssen Vaccines & Prevention B.V. AW has received funding from NIH, GlaxoSmithKline and Sanofi and has been a consultant for Aicuris, X-Vax, Vir, Crozet, and Auritec. ACK reported clinical trials contract funding for vaccines or MAB vs SARS-CoV-2 with Regeneron and Pfizer. AFL has received research grant support to UCSF from Astra Zeneca. The Washington University Clinical Trials Unit has received unrelated funding support in sponsored research agreements from Moderna. PAG receives grant funding from the NIH and is a consultant for Johnson and Johnson.

Clinical Trial

NCT05289037

Funding Statement

The trial was sponsored and funded by the National Institute of Allergy and Infectious Diseases.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The trial was reviewed and approved by the Advarra central institutional review board which gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 15, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R. Branche, Nadine G. Rouphael, David J. Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden, Sharon E. Frey, Jennifer A. Whitaker, Susan J. Little, Evan J. Anderson, Emmanuel B. Walter, Richard M. Novak, Richard Rupp, Lisa A. Jackson, Tara M. Babu, Angelica C. Kottkamp, Anne F. Luetkemeyer, Lilly C. Immergluck, Rachel M. Presti, Martín Bäcker, Patricia L. Winokur, Siham M. Mahgoub, Paul A. Goepfert, Dahlene N. Fusco, Elissa Malkin, Jeffrey M. Bethony, Edward E. Walsh, Daniel S. Graciaa, Hady Samaha, Amy C. Sherman, Stephen R. Walsh, Getahun Abate, Zacharoula Oikonomopoulou, Hana M. El Sahly, Thomas C.S. Martin, Christina A. Rostad, Michael J. Smith, Benjamin G. Ladner, Laura Porterfield, Maya Dunstan, Anna Wald, Tamia Davis, Robert L. Atmar, Mark J. Mulligan, Kirsten E. Lyke, Christine M. Posavad, Megan A. Meagher, David S. Stephens, Kathleen M. Neuzil, Kuleni Abebe, Heather Hill, Jim Albert, Teri C. Lewis, Lisa A. Giebeig, Amanda Eaton, Antonia Netzl, Samuel H. Wilks, Sina Türeli, Mamodikoe Makhene, Sonja Crandon, Marina Lee, Seema U. Nayak, David C. Montefiori, Mat Makowski, Derek J. Smith, Paul C. Roberts, John H. Beigel, the COVAIL Study Group
medRxiv 2022.07.12.22277336; doi: https://doi.org/10.1101/2022.07.12.22277336
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R. Branche, Nadine G. Rouphael, David J. Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden, Sharon E. Frey, Jennifer A. Whitaker, Susan J. Little, Evan J. Anderson, Emmanuel B. Walter, Richard M. Novak, Richard Rupp, Lisa A. Jackson, Tara M. Babu, Angelica C. Kottkamp, Anne F. Luetkemeyer, Lilly C. Immergluck, Rachel M. Presti, Martín Bäcker, Patricia L. Winokur, Siham M. Mahgoub, Paul A. Goepfert, Dahlene N. Fusco, Elissa Malkin, Jeffrey M. Bethony, Edward E. Walsh, Daniel S. Graciaa, Hady Samaha, Amy C. Sherman, Stephen R. Walsh, Getahun Abate, Zacharoula Oikonomopoulou, Hana M. El Sahly, Thomas C.S. Martin, Christina A. Rostad, Michael J. Smith, Benjamin G. Ladner, Laura Porterfield, Maya Dunstan, Anna Wald, Tamia Davis, Robert L. Atmar, Mark J. Mulligan, Kirsten E. Lyke, Christine M. Posavad, Megan A. Meagher, David S. Stephens, Kathleen M. Neuzil, Kuleni Abebe, Heather Hill, Jim Albert, Teri C. Lewis, Lisa A. Giebeig, Amanda Eaton, Antonia Netzl, Samuel H. Wilks, Sina Türeli, Mamodikoe Makhene, Sonja Crandon, Marina Lee, Seema U. Nayak, David C. Montefiori, Mat Makowski, Derek J. Smith, Paul C. Roberts, John H. Beigel, the COVAIL Study Group
medRxiv 2022.07.12.22277336; doi: https://doi.org/10.1101/2022.07.12.22277336

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10779)
  • Forensic Medicine (8)
  • Gastroenterology (583)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (864)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)